Shortened multidrug-resistant tuberculosis regimens overcome low-level fluoroquinolone resistance

Eur Respir J. 2017 Jun 1;49(6):1700223. doi: 10.1183/13993003.00223-2017. Print 2017 Jun.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antitubercular Agents
  • Fluoroquinolones*
  • Humans
  • Microbial Sensitivity Tests
  • Mycobacterium tuberculosis
  • Tuberculosis, Multidrug-Resistant*

Substances

  • Antitubercular Agents
  • Fluoroquinolones